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Abstract
Background: Recent studies have reported that patients with end-stage heart disease can have cognitive deficits ranging
from mild to severe. Little is known, however, about the relationship between cognitive performance, neurophysiological
characteristics and relevant clinical and instrumental indexes for an extensive evaluation of patients with heart failure, such
as: left ventricular ejection fraction (LVEF) and other haemodynamic measures, maximum oxygen uptake during
cardiopulmonary exercise testing, comorbidities, major cardiovascular risk factors and disease duration. Our purpose was to
outline the cognitive profiles of end-stage heart disease patients in order to identify the cognitive deficits that could
compromise the quality of life and the therapeutic adherence in end-stage heart disease patients, and to identify the
variables associated with an increased risk of cognitive deficits in these patients.
Methods: 207 patients with end-stage cardiac disease, candidates for heart transplant, were assessed by complete
neuropsychological evaluation and by electroencephalographic recording with EEG spectral analysis.
Results: Pathological scores in one or more of the cognitive tests were obtained by 86% of the patients, while 36%
performed within the impaired range on five or more tests, indicating poor performance across a broad range of cognitive
domains. The executive functions were the cognitive domain most impaired (70%). Poor performances were not related to
the aetiology of heart disease, but rather to cerebral dysfunction secondary to haemodynamic impairment and to
comorbidities.
Conclusions: Severe heart failure induces significant neurophysiological and neuropsychological alterations, which may
produce an impairment of cognitive functioning and possibly compromise the quality of life of patients and the therapeutic
adherence.
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Introduction
Low cardiac output associated with heart failure often leads to
end-organ damage including brain injury. In 1977, heart failure
was proposed as a possible cause of cognitive dysfunction,
introducing the term ‘‘cardiogenic dementia’’ [1]. However, only
a limited number of clinical studies have systematically evaluated
the cognitive profile of heart failure patients [2]. Furthermore,
most of these studies only focused on elderly patient populations in
which a high prevalence of cognitive deficits and a decrease in the
quality of life were demonstrated in the case of severe heart failure
[3–5]. There is also considerable evidence to show that cognitive
impairments in geriatric patients with cardiovascular disease are
due to cerebral hypoperfusion secondary to impaired cardiac
function since the homeostatic mechanisms involved in maintain-
ing haemodynamic regulation break down as people age [6,7].
In contrast, relatively few studies have examined the neuropsy-
chological performance in younger patients scheduled for cardiac
transplantation, even though some early studies [8–10] revealed a
high incidence of organic neurologic complications in cardiac
transplant patients. Moreover, few of them investigated a large
range of cognitive functions in a large sample of end-stage heart
disease patients [11,12]. The study by Putzke and colleagues
provided descriptive neuropsychological data for a very large
group of 760 patients, and certainly improved on previous studies
that were limited by a relatively small sample size [13,14]. Their
results showed that the types of cardiac diagnosis and cardiac
surgical history were not related to cognitive functioning. This
finding increased the need to consider other clinical features and
comorbidity factors that might be more closely related to cognitive
impairment in end-stage disease patients [15]. Moreover, it has
been previously observed that cerebrovascular complications
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structure [16,17]. However, how brain abnormalities are associ-
ated with clinical factors and cognitive performance in end-stage
heart disease patients is poorly understood. Studies of cognitive
function in the context of heart transplantation are needed for
several reasons. Patients must understand and participate in the
decision-making process before surgery. Furthermore, cognitive
functions can influence the ability to understand and to adhere to
post-transplant treatment protocols. Neurological and/or neuro-
psychological morbidity before, during and after heart transplan-
tation is not infrequent. Cognitive disorders could affect the basic
activities of daily living, such as, for example, driving, financial
planning, bill paying, shopping, meal preparation ect. Finally,
studies on patients who need heart transplantation may provide
data for a better understanding of the mechanisms underlying
cognitive deficits in any severe heart disease population.
Basically, four important issues surrounding this population of
patients need to be explored: [1] Is it possible to define a
characteristic cognitive profile for this population? Are there some
cognitive functions that are more impaired than others? Are those
cognitive functions involved in adherence to therapy extensively
compromised? [2] Is there any relationship between specific
cognitive deficits, aetiology and the natural history of cardiopathy?
[3] Are there any relationships between a single parameter of
haemodynamic failure or any other clinical findings and severity
or specificity of cognitive deficits? [4] How indexes of brain
functioning (EEG) may be related to parameters of hemodynamic
failure and cognitive performance in these patients?
We conducted a very complete neuropsychological and
neurophysiological assessment in order to identify the particular
profile of end-stage cardiac patients. Furthermore, we studied the
executive functions in detail since that they are important not only
for the quality of life but also for the management of therapy and
medication adherence [18–20], as taking medicines consistently
involves developing and implementing a plan of adherence and
remembering to adhere to it. Medication adherence strongly
depends on prospective memory and may also involve working
memory, since the patient must keep the intention to take the
medicine active in their working memory while doing other things
[21].
Materials and Methods
The ethic committee of the Hospital of Padua approved the
study. All clinical investigations have been conducted according to
the principles expressed in the declaration of Helsinki. All patients
gave their written consent before to take part in the study.
A consecutive sample of 207 patients (age: 53.33613.6;
education in years: 8.3964.19) with end-stage cardiac disease
who underwent routine psychological and neuropsychological
evaluation prior to acceptance into the heart transplant pro-
gramme were studied.
None of the patients had previous severe brain injury and or
psychiatric illness. Moreover, all patients were assessed by a
clinical semi-structured interview and administration of the
Minesota Multiphasic Personality Inventory (MMPI-2) [22]. None
of them had any abnormal scores in scale of depression (scale D)
and in scale of anxiety (scales Pt and A). Patients in our sample
were treated with standard medications for chronic compensated
heart failure (diuretics, vasodilators, beta-blockers, etc.). This
treatment generally improves hemodynamic, thus increasing renal
and hepatic function and cerebral flow. During acute phase of
congestive heart failure higher dosage of diuretics may cause
mental confusion and acute cognitive impairment due to de-
hydration or alterations of electrolytes serum levels, but cognitive
and psychological assessments were not performed during acutely
decompensate heart failure.
Three groups were considered on the basis of the type of cardiac
disease: ischaemic dilated cardiomyopathy (IDC); non-ischaemic
dilated cardiomyopathy (NIDC); miscellaneous (M). The miscel-
laneous category included: Cardiomyopathy, hypertrophic car-
diomyopathy, congenital heart disease, late post-surgical failure of
heart disease. The demographic and clinical characteristics are
illustrated in Table 1.
Neuropsychological measures
All patients underwent routine neuropsychological assessment
by the Mini Mental State Examination (MMSE) [23] and by a
well-validated battery for the Italian population, the Esame
Neuropsicologico Breve (ENB, Short Neuropsychological Exam-
ination) [24]. Each patient was assessed individually by experi-
enced neuropsychologists and the assessment test lasted one hour.
The MMSE consists of a brief 30-point questionnaire that is
used to screen for cognitive decline (cut-off score: 24). Further-
more, each subject was assessed by the Token test [25–26] to
verify comprehension. This test assesses verbal comprehension of
verbal commands of increasing complexity. The test required
patients to point tokens on the basis of their colour, shape and size.
The ENB battery investigates different cognitive domains and
encompasses thirteen tests: Token test, Trial Making Test, Digit
span, Logical story, Interference memory, Cognitive estimation,
Abstract verbal reasoning, Phonemic fluency test, Clock drawing
test, Overlapping pictures test, Spontaneous drawing, Copy
drawing, Ideative and ideomotor praxis test. The tests were
chosen to cover five cognitive domains: attention, memory,
executive functions, and perceptive and praxis abilities. The
cognitive domain of attention included the Trial Making Test A
and the Trial Making Test B; the domain of memory included
Digit Span, Logical Story and Interference memory tests; the
cognitive domain of executive function included Trial Making
Test B, Cognitive estimation, Abstract reasoning, Phonemic
fluency, Clock drawing, and Overlapping pictures tests. The
domain of perception included Spontaneous drawing and Copy
drawing tests. One test accounted for more than one domain
(Table 2): the Trail Making Test B (TMTB) is a well-known
instrument for describing the attentive function but at the same
time it evaluates switching ability and working memory (i.e.
executive functions); thus, it requires the involvement of executive
functions [27].
Psychometric tests were expressed by age and education
adjusted Z scores, i.e. in units of standard deviation stratified on
the basis of age and education level in the reference population of
normal individuals. For each test, a Z score equal to or lower than
22 was considered to be abnormal. For each individual, we
calculated both the number of abnormal tests and the mean Z
psychometric index (mZPSI) that summarized the Z scores of all tests
separately for each cognitive domain. This measure was used as an
overall synthetic index of cognitive performance.
A series of statistical analyses was conducted to determine which
clinical features and cardiovascular risk factors were significant
predictors of cognitive performance. All analyses were performed
with SPSS 15.0 (Statistical Package for Social Science, Chicago,
IL). All p values were two-tailed and a level of p,0.05 was
accepted as statistically significant.
In the first step, data were explored by correlational analysis on
continuous clinical variables and scores of cognitive tests (mZPSI
for each cognitive domain). In the second step, univariate
ANOVA and independent-sample t tests were performed in order
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cognitive domain on the basis of the category of heart disease,
years from diagnosis and different indexes including cardiopul-
monary assessment, comorbidities and cardiovascular risk factors.
For these analyses, continuous variables for comprehensive pre-
transplant cardiopulmonary assessment were considered as
categorical cut-off values, used to determine the classification of
patients: LVEF=30%; cardiac index=2.5 L/min/m2; mean
Table 1. Clinical features and cardiovascular risk factors by heart disease.
Variables IDC (n=75; 39.5%) NIDC (n=52; 27.4%) M (n=63; 33.2%) Comparison (p value)*
Sex (males) 93.3% 73.1% 63.5% p,0.001
Age 2.260,5 23.366.7 17.1616.8 ns
Years from diagnosis 29.9% 96.062,5 2.360,7 p,0.01
Ejection fraction (%) 47.2% 15.6% 96.363.5 p,0.001
Cardiac index (L/min/m
2) 88.3% 36.0% 34.4% p,0.01
VO2max (L/min/Kg) 93.3% 48.8% 17.9% p,0.01
SaO2 (%) 2.260,5 73.1% 34.9% ns
Mean PAP (mmHg) 29.9% 23.366.7 44.1% ns
Atrial fibrillation 47.2% 96.062,5 46.2% ns
Carotid artery stenosis { 88.3% 15.6% 63.5% p,0.001
Previous TIA/stroke { 93.3% 36.0% 17.1616.8 ns
Hepatic dysfunction 1 2.260,5 48.8% 2.360,7 ns
Renal dysfunction 1 29.9% 73.1% 96.363.5 ns
Respiratory dysfunction 1 47.2% 23.366.7 34.4% ns
Hyperglycemia I 88.3% 96.062,5 17.9% p,0.001
Dyslipidemia 93.3% 15.6% 34.9% p,0.001
Smokers 2.260,5 36.0% 44.1% p,0.001
IDC: ischemic dilated cardiomyopathy; NIDC: non-ischemic dilated cardiomyopathy; M: miscellaneous cardiac diseases; PAP: pulmonary artery pressure.
*Subgroups were compared by X
2 (categorical variables) or one-way analysis of variance (continuous variables).
{Medium to high grade.
{Transient ischemic attacks (TIA) or stroke.
1Moderate to severe.
IImpaired glucose tolerance (IGF) or impaired fasting glucose (IFG) or diabetes mellitus.
doi:10.1371/journal.pone.0028313.t001
Table 2. Neuropsychological domain and psychometric tests.
Cognitive Domain Psychometric test Z mean ± sd Patients with altered test
Attention TMT-A 0.2561.69 12.6%
TMT-B 0.6261.83 18.8%
Memory Digit Span 20.4561.11 15.9%
Logical story: immediate recall 20.3961.13 13.5%
Logical story: delayed recall 20.6260.99 15.5%
Interference memory test 10 s. 20.4561.30 21.7%
Interference memory test 30 s. 20.6261.60 19.8%
Executive function TMT-B 0.6261.83 18.8%
Cognitive estimation 20.9062.22 27.1%
Abstract verbal reasoning 20.2261.11 11.5%
Phonemic fluency test 21.0061.84 38.2%
Clock drawing test 20.9261.95 23.7%
Overlapping pictures test 21.4461.29 44.4%
Perception Spontaneous drawing 0.8062.19 19.8%
Copy drawing 0.4161.56 20.8%
Praxis ability Ideative and ideomotor praxis test 20.6762.30 15.0%
Mean, standard deviation and % of patients with deficits (Z scores below 2 standard deviations).
doi:10.1371/journal.pone.0028313.t002
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saturation=97% (median value); VO2max=11.2 ml/min/kg
(median value); disease duration (years from diagnosis of heat
disease)=6 years (median value). All tests were corrected for
multiple comparisons using the false discovery rate method of
Benjamini and Hochberg (FDRBH) [28]. With this method, tests
were corrected for the number of comparisons conducted on a
single dependent variable.
Neurophysiological measures
A subgroup of 60 consecutive patients underwent digital
electroencephalographic recording. To evaluate whether this
subgroup of patients was comparable to the overall sample we
compared patients with and without EEG measures on all the
cardiovascular variables (i.e., IC, LVEF, VO2max, etc.) and
comorbidities and risk factors (i.e., previous ischemic attach and
hepatic dysfunction, etc.) considered in this study. No differences
were detected between the two subgroups of patients.
Spontaneous closed-eyes activity was recorded by digital EEG
equipment (Brainquick 3200, Micromed, Italy). A standard 21-
channel cap (Micromed, Italy) was used, and the electrodes placed
according to the 10–20 International System [29]. The EEG
tracing was assessed by spectral analysis after visual inspection to
exclude artefacts. Spectral analysis was carried out on the
derivation T4-O2, T3-O1 and P3-P4 in the frequency range of
1–25.5 Hz [30]. The variables considered for statistical analyses
were the mean dominant frequency (MDF), i.e., the mean
frequency weighted by the power of each frequency band, and
the relative power of alpha, theta, and delta bands, i.e., the
percentage of the absolute power of the spectrum due to alpha,
theta, and delta activity, respectively. These variables were
correlated both with clinical features/cardiovascular risk factors




Results showed that 96% of the patients had a normal ability of
comprehension, which is consistent with the high reliability of
cognitive tests.
The total sample mean score of the MMSE was 26.963.1.
Following the norms published by Crums for mean age of 53 years
[31], 30% of patients showed impaired MMSE scores, but 86%
had one or more cognitive tests altered. The fact that no more
than 30% of patients showed impaired MMSE is not surprising
since the MMSE may detect cognitive impairment less effectively
because of the ceiling effect, the lack of learning condition, and the
absence of specific items evaluating executive functions. In fact,
detailed neuropsychological evaluation showed that 36% failed
five or more tests, indicating broad neuropsychological impair-
ment. In detail, executive functions were impaired in 70%,
perception in 31%, memory in 51%, attention in 26%, and praxis
abilities in 15% out of the whole sample (Table 2). Cognitive
performance in the domain of attention was directly correlated
with LVEF (R=0.17, p,0.05) and inversely correlated with index
of renal dysfunction (R=20.16, p,0.05). Moreover, the global
cognitive performance of patients (mZPSI averaged across all
cognitive domains) was directly correlated with the cardiac index
(R=0.20, p,0.05) and inversely correlated with index of renal
dysfunction (R=20.17, p,0.05).
A worse performance in the domain of perception was found in
patients with a cardiac index ,2.5 l/min/m
2. No significant
differences were found in cognitive performance on the basis of
pre-transplant VO2max, LVEF, atrial fibrillation/flutter, arterial
haemoglobin saturation, or pulmonary artery pressure during
right heart catheterization. Regarding comorbidities, previous
cerebral ischaemic attacks were associated with significantly lower
performances in the memory domain. The presence of hepatic
dysfunction was associated with lower performance in the
cognitive domain of attention. Regarding atherosclerotic risk
factors, hyperglycaemia was associated with lower performance in
attention. Detailed results are shown in table 3.
Consistently with previous studies [2,11], no differences were
found in cognitive performance between the aetiological groups
considered: ischaemic dilated cardiomyopathy (IDC); non-ischae-
mic dilated cardiomyopathy (NIDC); miscellaneous (M).
Neurophysiological results
The ejection fraction of the left ventricle showed an inverse
relationship with the electroencephalogram delta relative power
on both temporal derivations (R=20.30 and R=20.25 on the
left and right hemispheres, respectively: both p,0.05) and
biparietal derivations (R=20.27 p,0.05). In addition, the cardiac
index was found to be inversely correlated with the electroen-
cephalogram theta relative power in temporal derivations
(R=2043, p,0.05 and R=20.31, p,0.05 on the left and right
hemispheres, respectively). The electroencephalogram was also
found to be related to the indices of liver function: delta power was
directly related to the bilirubin plasma level on both temporal and
biparietal derivations (left temporal: R=0.37, p,0.05; right
temporal: R=0.26, p,0.05; biparietal: R=0.36, p,0.05) and
theta relative power was directly related to cGT (left temporal:
R=0.28, p,0.03; right temporal: R=0.25, p,0.05 and bipari-
etal: R=0.30, p,0.05). Cognitive performance in the domain of
attention was directly related to theta relative power on both
temporal (R=0.29 and R=0.33 on the left and right hemispheres,
respectively: both p,0.05) and biparietal derivations (R=0.30,
p,0.05).
Discussion
Increased prevalence (53–58%) of mild cognitive impairment,
particularly memory, has previously been demonstrated in older
populations with heart failure [3–5,32]. Cognitive dysfunction in
these patients correlates with reduced ventricular function; both
imaging and neurological examinations have evidenced white
matter lesions in older demented patients with heart failure,
systolic hypotension, decreased cerebral blood flow and multiple
vascular risk factors, as are commonly found in the elderly.
For a long time, during the evaluation of younger candidates for
heart transplant, our attention has been focused on psychological
findings, assuming that abnormalities in behaviour and the
prevalence of depression and anxiety were mainly the result of
the seriousness and duration of heart disease. Conversely, the
growing amount of data about cognitive deficits after transplan-
tation support the hypothesis of structural cerebral damage related
to the status of chronic heart failure. In fact, various causes may be
associated with cerebral damage in patients with heart failure, also
at a younger age. The combination of abnormal intracardiac
blood flow, endothelial dysfunction and rheological abnormalities
present in patients with chronic heart failure satisfies Virchow’s
triad and suggests that, particularly in the setting of left ventricular
dysfunction, heart failure is a hypercoagulable state: a risk factor
for subclinical or clinical stroke. Moreover, other causes of
cerebral damage can include reduced auto-regulation of cerebral
circulation, altered cerebrovascular reactivity, increased blood
viscosity, and chronic use of drugs (digoxin and over-diuresis).
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neurophysiological assessment must be associated with the
psychological examination of candidates of heart transplantation,
with care being taken to study their executive functioning, which is
particularly involved in the pre-transplant decision-making process
in terms of the understanding and acceptance of this exceptional
event. Moreover, these aspects are determinants for quality of life
and the persistence of adherence to treatment after transplant.
The prognostic value of cognitive and psychological abnormalities
is not exclusively correlated with the severity and duration of
cardiopathy, but also with the presence and gravity of morbidity,
including cerebral and visceral dysfunctioning.
The results of the present study indicated that end-stage heart
failure patients showed a significant decline in cognitive function-
ing. In accordance with previous studies [11,12,5], we found that
86% of our sample obtained abnormal scores in at least one test
and that 36% performed within the impaired range in five or more
tests, indicating poor performance across a broad range of
cognitive domains. These abnormalities were not related to the
aetiology of heart disease, but rather to cerebral damage secondary
to altered cardiac pump functioning. Even if atherosclerotic risk
factors such as diabetes, arterial hypertension, a high plasma level
of cholesterol and smoking were more prevalent in patients with
IDC, these patients did not show greater cognitive alterations than
patients in the other two groups.
We studied the impairments in cognitive functions through an
exhaustive neuropsychological investigation in order to delineate
the cognitive profile of end-stage heart failure patients. The results
showed that the most impaired cognitive domains were those
related to executive functions, followed by perception, memory,
attention and praxis abilities. Cognitive functions, and particularly
executive functions and prospective memory and working
memory, are certainly key determinants of an end-stage heart
failure transplant recipient’s ability to manage the complex
treatment regimen and gain maximum benefit from this surgical
procedure. Compliance after cardiac transplantation is multifac-
eted and involves adhering to a prescribed diet and lifestyle,
keeping scheduled medical appointments, the maintenance of
communication, and, ultimately, adherence to the immunosup-
pressive regimen.
Our data, in agreement with previous studies [2,11,15],
corroborated the suspicion that cognitive deficits are unrelated
to the aetiology of heart disease. The results showed that other
important variables help to delineate the cognitive profile of end-
stage heart patients. A low cardiac index (,2.5 L/min/m
2) was
associated with the level of cognitive performance in the domain of
perception. Our results also stress the importance of comorbidity;
in fact, patients with previous cerebral ischaemic illness showed
deficits in the cognitive memory domain. Interestingly, the
presence of hepatic dysfunction was associated with deficits in
the domain of attention.
Patients estimated to be at higher risk of cognitive deficits may
require more attention and more intensive monitoring because
these deficits could potentially interfere not just with daily living
activities but also with medical adherence. Our data also provided
evidence that cognitive deficits are strictly correlated with cerebral
hypoperfusion and/or cerebral alteration, as supported by the
neurophysiological results. The inverse correlation between the
LVEF and electroencephalogram delta power is in agreement with
the noxious effect of cerebral hypoperfusion, owing to reduced
heart functioning. In fact, an increase in electroencephalogram
delta activity is a marker of brain damage [33]. A further index of
the harmful effect of hypoperfusion on the brain was provided by
the inverse correlation between the cardiac index and electroen-
cephalogram theta power in the temporal derivations. In addition,
temporal lobes are known to be highly susceptible to brain
hypoperfusion and there is some evidence that mild cognitive
impairment could be associated with hypoperfusion in these
cortical areas [34]. The relationship between high plasma levels of
bilirubin and cGT and a slowing of the electroencephalogram
could suggest the possibility of an altered cerebral physiology in
patients with secondary liver dysfunction due to heart failure.
Our data on neuropsychological and neurophysiological deficits
in end-stage heart disease candidates for transplant stressed the
importance of close collaboration across a range of disciplines in
order to establish a programme of research and professional
education. We need to develop clinical practice guidelines and
pathways, which support the implementation of best practice in the
assessment and management of comorbid cognitive and neuro-
physiological alterations in patients with end-stage heart failure.
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Previous cerebral ischaemic attacks yes 20.9661.37 p,0.05
no 20.4960.81
Hepatic dysfunction yes 20.9461.74 p,0.05
no 20.0561.37
Hyperglycemia yes 20.7561.85 p,0.05
no 20.0461.09
Values represent results of ANOVA test on mZPSI (see Materials and Methods).
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Cognitive Profile in Heart Transplant Candidates
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e28313References
1. Editorial (1977) Cardiogenic dementia. Lancet 1: 27–8.
2. Vogels RLC, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2009) Cognitive
impairment in heart failure: A systematic review of the literature. Eur J of Heart
Fail 9: 440–449.
3. Roma ´n CG, Sachdev P, Royall DR, Bullock RA (2004) Vascular cognitive
disorder: a new diagnostic category updating vascular cognitive impairment and
vascular dementia. J Neurol Sci 226: 81–7.
4. Fahlander K, Wahli A, Fastbom J, Grut M, Forsell Y, et al. (2000) The
Relationship Between Signs of Cardiovascular Deficiency and Cognitive
Performance in Old Age: A Population-Based Study. J Gerontol B Psychol Sci
Soc Sci 55: 259–265.
5. Bennet SJ, Sauve ` MJ (2003) Cognitive deficits in patients with heart failure: a
review of literature. J Cardiovasc Nurs 18: 219–242.
6. Cohen RA, Poppas A, Forman DE, Hoth KF, Haley AP, et al. (2009) Vascular
and cognitive functions associated with cardiovascular disease in the elderly.
J Clin Exp Neurospsyc 31: 96–110.
7. Verhaegen P, Borchelt M, Smith J (2003) Relation between cardiovascular and
metabolic disease and cognition in very old age: Cross-sectional and longitudinal
findings from the Berlin aging study. Health Psychol 22: 559–569.
8. Ang LC, Gillet JM, Kaufmann JC (1989) Neuropathology of heart transplan-
tation. Can J Neurol Sci 16: 291–298.
9. Montero CG, Martinez AJ (1986) Neuropathology of heart transplantation: 23
cases. Neurology 36: 1149–1154.
10. Lee CW, Lee JH, Kim JJ, Park SW, Hong MK, et al. (1999) Cerebral metabolic
abnormalities in congestive heart failure detected by proton magnetic resonance
spectroscopy. J Am Coll Cardiol 33: 1196–1202.
11. Putzke JD, Williams MA, Millsaps CL, Azrin RL, LaMarche JA, et al. (1997)
Heart Transplant Candidates: A Neuropsychological Descriptive Database.
J Clin Psychol Med S 4: 343–355.
12. Deshields TL, McDonough EM, Mannen RK, Miller LW (1996) Psychological
and cognitive status before and after heart transplantation. Gen Hosp Psychiatry
18: 62S–69S.
13. Schall R, Petrucci RJ, Brozena SC, Cavarocchi NC, Jessup M (1989) Cognitive
function in patients with symptomatic dilated cardiomyopathy before and after
cardiac transplantation. J Am Coll Cardiol 14: 1666–1672.
14. Bornstein RA, Starling RC, Myerowitz PD, Haas GJ (1995) Neuropsychological
function in patients with end stage failure before and after heart transplantation.
Acta Neurol Scand 91: 260–265.
15. Putzke JD, Williams MA, Daniel FJ, Foley BA, Kirklin JK, et al. (2000)
Neuropsychological functioning among heart transplant candidates: A case
control study. Journal of Clinical and Experimental Neuropsychology 22:
95–103.
16. Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, et al.
(2007) Brain magnetic resonance imaging abnormalities in patients with heart
failure. Eur J Heart Fail 9: 1003–1009.
17. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus MD, et al. (1994)
Cerebral white matter lesions, vascular risk factors, and cognitive function in a
population-based study: the Rotterdam Study. Neurology 44: 1246–1252.
18. Moscovitch M (1994) Memory and working with memory: Evaluation of a
component process model and comparisons with other models. In: Schacter DL,
Tulving E, eds. Memory systems. CambridgeMA: The MIT Press. pp 269–310.
19. Schillerstrom JE, Horton MS, Royall DR (2005) The Impact of Medical Illness
on Executive Function. Psychosomatics 46: 508–516.
20. McDonald-Miszczak L, Neupert S, Gutman G (2009) Does Cognitive Ability
Explain Inaccuracy in Older Adults’ Self-Reported Medication? J Appl Gerontol
28: 560–581.
21. Insel K, Morrow D, Brewer B, Figueredo AA (2006) Executive function, working
memory, and medication adherence among older adults. J Gerontol B Psychol
Sci Soc Sci 6: 102–107.
22. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B (1989) The
Minnesota Multiphasic Personality Inventory-2 (MMPI-2): Manual for admin-
istration and scoring. MinneapolisMN: University of Minnesota Press.
23. Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State. A practical
method for grading the cognitive state of patients for clinician. J Psych Res 12:
189–198.
24. Mondini S, Mapelli D, Vestri A, Bisiacchi P (2003) ENB Esame Neuropsico-
logico Breve, Raffaello Cortina, MI.
25. De Renzi A, Vignolo LA (1962) Token test: A sensitive test to detect receptive
disturbances in aphasics. Brain 85: 665–678.
26. Spinnler M, Tognoni G (1987) Standardizzazione e taratura italiana di test
neuropsicologici. Ital J Neurol Sci Suppl 8 n.6.
27. Lezak MD (1995) Neuropsychological assessment. New York: Oxford University
Press.
28. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical
and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol
57: 289–300.
29. Klem GH, Lu Ders HO, Jasper HH, Elgar C (1999) The ten-twenty electrode
system of the International Federation. Recommendations for the Practice of
Clinical Neurophysiology: Guidelines of the International Federation of Clinical
Physiology. Electroenceph Clin Neurophysiol 52(Suppl): 3–6.
30. Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, et al.
(1999) Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin
Neurophysiol 110: 1334–1344.
31. Crum RM, Anthony JC, Bassett SS, Folstein MF (1993) Population-based norms
for the Mini-Mental State Examination by age and educational level. JAMA-J
Am Med Assoc 12; 269(18): 2386–2391.
32. Trojano L, Antonelli Incalzi R, Acanfora D, Picone C, Mecocci P, et al. (2003)
Cognitive impairment: a key feature of congestive heart failure in the elderly.
J Neurol 250: 1456–1463.
33. Niedermeyer E, Lopes da Silva F (2005) Electroencephalography: Basic
Principles, Clinical Applications, and Related Fields. 5th edition. Philadelphia:
Lippincott Williams & Wilkins.
34. Wang H, Chu Y, Bert A, Chang V, Golob E, et al. (2004) P2-183 Regional
cerebral hypoperfusion of medial temporal lobe in mild cognitive impairment.
Neurobiol Aging 25: S279.
Cognitive Profile in Heart Transplant Candidates
PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28313